Skip to main content
. 2014 Aug 19;8:1125–1134. doi: 10.2147/DDDT.S64261

Figure 1.

Figure 1

Study design.

Notes: Treatments consisted of two tablets of ER OC/APAP (15 mg OC/650 mg APAP) under: A) high-fat meal fed condition; B) low-fat meal fed condition; and C) fasted condition. aDuration of approximately 60 hours each, including an initial overnight (10-hour) fast, predose assessments and blood draws, and postdose pharmacokinetic sampling for 48 hours; b≥7 days; cparticipants were released from the study following their 48-hour blood draw and completion of the 48-hour postdose safety assessments; dongoing adverse events were followed via telephone for 7 days (with a visit window of plus 2 days) after period 3 study exit or early termination.

Abbreviations: APAP, acetaminophen; ER, extended release; OC, oxycodone.